Lynda Chin, MD
Associate Vice Chancellor for Health Transformation & CIO for Health Affairs, University of Texas System
Renowned physician and researcher Lynda Chin, M.D., is The University of Texas System’s associate vice chancellor for health transformation and chief innovation officer for health affairs. Chin leads the UT System’s Institute for Health Transformation, which leverages, develops and deploys innovative, technology-enabled solutions to improve access and affordability of quality health care in Texas and beyond. Prior to joining the UT System in 2015, Chin was the founding chair of Genomic Medicine and scientific director of the Institute for Applied Cancer Science at UT MD Anderson Cancer Center. She has won numerous distinguished honors, including election to the prestigious Institute of Medicine (IOM) of the National Academies in 2012. On October 6, 2016, Dr. Chin was appointed by the National Academies of Sciences, Engineering, and Medicine to a committee that will help guide U.S. policy on global health.
Dr. Chin is one of 14 members appointed to the Committee on Global Health and the Future of the United States by the National Academies, the U.S. government’s most influential adviser on public policy decisions related to science, technology and medicine. Dr. Chin and her fellow members are among the nation’s thought leaders on global health and global health security, infectious and non-communicable chronic diseases, as well as technology and business innovations.
Dr. Chin, an accomplished physician scientist and a member of the prestigious National Academy of Medicine, currently is spear-heading the UT System’s Project DOC (Diabetes Obesity Control), which uses innovative new technology and cross-enterprise collaborations so that diabetic patients in South Texas have better access to care and more effective control of the chronic disease.
“In today’s world, global health is local health. Project DOC has taught us lessons that are directly applicable to challenges elsewhere,” said Dr. Chin, also director of UT System’s Institute for Health Transformation. “Project DOC has put us at the forefront of innovation in data, analytics and transforming our health care ecosystem. I am proud that the work here in our own backyard can contribute to a broader health strategy domestically and globally.”
Prior to joining the UT System in 2015, Dr. Chin was the founding chair of Genomic Medicine and scientific director of the Institute for Applied Cancer Science at UT MD Anderson Cancer Center. She has made multiple scientific discoveries spanning the fields of transcription, telomere biology, cancer genomics, and personalized cancer medicine, and more recently big data and cognitive analytics. Dr. Chin is internationally known for her pioneering work in genomics and analytics and has won numerous distinguished honors for her scientific contributions.
“Dr. Chin is a thought leader in developing bold and innovative health care solutions,” said Ray Greenberg, M.D., Ph.D., executive vice chancellor for health affairs. “The National Academies’ committee – and the nation’s health care policy – will benefit greatly from Dr. Chin’s expertise and vision."
Dr. Chin, an accomplished physician scientist and a member of the prestigious National Academy of Medicine, currently is spear-heading the UT System’s Project DOC (Diabetes Obesity Control), which uses innovative new technology and cross-enterprise collaborations so that diabetic patients in South Texas have better access to care and more effective control of the chronic disease.
“In today’s world, global health is local health. Project DOC has taught us lessons that are directly applicable to challenges elsewhere,” said Dr. Chin, also director of UT System’s Institute for Health Transformation. “Project DOC has put us at the forefront of innovation in data, analytics and transforming our health care ecosystem. I am proud that the work here in our own backyard can contribute to a broader health strategy domestically and globally.”
Prior to joining the UT System in 2015, Dr. Chin was the founding chair of Genomic Medicine and scientific director of the Institute for Applied Cancer Science at UT MD Anderson Cancer Center. She has made multiple scientific discoveries spanning the fields of transcription, telomere biology, cancer genomics, and personalized cancer medicine, and more recently big data and cognitive analytics. Dr. Chin is internationally known for her pioneering work in genomics and analytics and has won numerous distinguished honors for her scientific contributions.
“Dr. Chin is a thought leader in developing bold and innovative health care solutions,” said Ray Greenberg, M.D., Ph.D., executive vice chancellor for health affairs. “The National Academies’ committee – and the nation’s health care policy – will benefit greatly from Dr. Chin’s expertise and vision."
Topics:
- COVID-19: How the Pandemic Reinforces the Value of Patient-centric Approach
Dr. Chin discusses how the pandemic is reinforcing the value of patient-centric approach… and by shifting the point-of-care and bringing clinical trials to patients’ homes, we are also narrowing the access disparity, especially for specialty care (like cancer) and novel therapies (like clinical trials). - Can Medical Industry and Medical Research Live Happily Ever After?
- Big Data and AI: Transforming Research and Care
- Building a Patient-Centric, Interoperable, Digitally Connected Healthcare Ecosystem
Looking for a speaker? Let us help you.
All fields are required.